Skip to main content

Articles

Page 1 of 104

  1. Changes in microcirculation of axillary lymph nodes (ALNs) may indicate metastasis. Reliable noninvasive imaging technique to quantify such variations is lacking. We aim to develop and investigate a contrast-f...

    Authors: Giulia Ferroni, Soroosh Sabeti, Tasneem Abdus-Shakur, Lorenzo Scalise, Jodi M. Carter, Robert T. Fazzio, Nicholas B. Larson, Mostafa Fatemi and Azra Alizad
    Citation: Breast Cancer Research 2023 25:65
  2. Researchers have suggested that longitudinal trajectories of mammographic breast density (MD) can be used to understand changes in breast cancer (BC) risk over a woman’s lifetime. Some have suggested, based on...

    Authors: Maya Illipse, Kamila Czene, Per Hall and Keith Humphreys
    Citation: Breast Cancer Research 2023 25:64
  3. Breast cancer presents as one of the top health threats to women around the world. Myeloid cells are the most abundant cells and the major immune coordinator in breast cancer tumor microenvironment (TME), targ...

    Authors: Chenxuan Yang, Jiaxiang Liu, Shuangtao Zhao, Qingyao Shang, Fei Ren, Kexin Feng, Ruixuan Zhang, Xiyu Kang, Xin Wang and Xiang Wang
    Citation: Breast Cancer Research 2023 25:63
  4. Although trastuzumab and other HER2-targeted therapies have significantly improved survival in patients with HER2 overexpressed or amplified (HER2+) breast cancer, a significant proportion of patients do not r...

    Authors: Shuying Liu, Shelly M. Xie, Wenbin Liu, Mihai Gagea, Ariella B. Hanker, Nguyen Nguyen, Akshara Singareeka Raghavendra, Gloria Yang-Kolodji, Fuliang Chu, Sattva S. Neelapu, Adriano Marchese, Samir Hanash, Johann Zimmermann, Carlos L. Arteaga and Debasish Tripathy
    Citation: Breast Cancer Research 2023 25:62
  5. Multiparametric magnetic resonance imaging (MP-MRI) has high sensitivity for diagnosing breast cancers but cannot always be used as a routine diagnostic tool. The present study aimed to evaluate whether the di...

    Authors: Manlin Lang, Ping Liang, Huiming Shen, Hang Li, Ning Yang, Bo Chen, Yixu Chen, Hong Ding, Weiping Yang, Xiaohui Ji, Ping Zhou, ligang Cui, Jiandong Wang, Wentong Xu, Xiuqin Ye, Zhixing Liu…
    Citation: Breast Cancer Research 2023 25:61
  6. Many factors, including reproductive hormones, have been linked to a woman’s risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs...

    Authors: Herjan J. T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, V. Craig Jordan, Paula Briggs, Jan F. M. Egberts, Kristina Gemzell-Danielsson, Ludwig Kiesel, Kirsten Kluivers, Jan Krijgh, Tommaso Simoncini, Frank Z. Stanczyk and Robert D. Langer
    Citation: Breast Cancer Research 2023 25:60
  7. Metastasis accounts for most cancer-associated deaths; yet, this complex process remains poorly understood, particularly the relationship between distant metastasis and primary site-derived cells. Here, we mod...

    Authors: Jin Biao Xu, Jun Cao, Jin Xia, Ying Zhu, Yi He, Ming Guo Cao, Bing Mu Fang, Jean Paul Thiery and Wu Zhou
    Citation: Breast Cancer Research 2023 25:59
  8. Endocrine-resistant HR+/HER2- breast cancer (BC) and triple-negative BC (TNBC) are of interest for molecularly informed treatment due to their aggressive natures and limited treatment profiles. Patients of Afr...

    Authors: Minoru Miyashita, Joshua S. K. Bell, Stephane Wenric, Ezgi Karaesmen, Brooke Rhead, Matthew Kase, Kristiyana Kaneva, Francisco M. De La Vega, Yonglan Zheng, Toshio F. Yoshimatsu, Galina Khramtsova, Fang Liu, Fangyuan Zhao, Frederick M. Howard, Rita Nanda, Nike Beaubier…
    Citation: Breast Cancer Research 2023 25:58
  9. Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Patients with TNBC are primarily treated with neoadjuvant chemotherapy (NAC). The response to NAC is prognostic, with reductio...

    Authors: Xiaojia Tang, Kevin J. Thompson, Krishna R. Kalari, Jason P. Sinnwell, Vera J. Suman, Peter T. Vedell, Sarah A. McLaughlin, Donald W. Northfelt, Alvaro Moreno Aspitia, Richard J. Gray, Jodi M. Carter, Richard Weinshilboum, Liewei Wang, Judy C. Boughey and Matthew P. Goetz
    Citation: Breast Cancer Research 2023 25:57
  10. Response assessment of targeted cancer therapies is becoming increasingly challenging, as it is not adequately assessable with conventional morphological and volumetric analyses of tumor lesions. The tumor mic...

    Authors: Emily Hoffmann, Mirjam Gerwing, Tobias Krähling, Uwe Hansen, Katharina Kronenberg, Max Masthoff, Christiane Geyer, Carsten Höltke, Lydia Wachsmuth, Regina Schinner, Verena Hoerr, Walter Heindel, Uwe Karst, Michel Eisenblätter, Bastian Maus, Anne Helfen…
    Citation: Breast Cancer Research 2023 25:56
  11. S100A6 and murine double minute 2 (MDM2) are important cancer-related molecules. A previous study identified an interaction between S100A6 and MDM2 by size exclusion chromatography and surface plasmon resonanc...

    Authors: Mengxin Qi, Xianglan Yi, Baohui Yue, Mingxiang Huang, Sheng Zhou and Jing Xiong
    Citation: Breast Cancer Research 2023 25:55
  12. Generalizable population-based studies are unable to account for individual tumor heterogeneity that contributes to variability in a patient’s response to physician-chosen therapy. Although molecular character...

    Authors: Joseph R. Peterson, John A. Cole, John R. Pfeiffer, Gregory H. Norris, Yuhan Zhang, Dorys Lopez-Ramos, Tushar Pandey, Matthew Biancalana, Hope R. Esslinger, Anuja K. Antony and Vinita Takiar
    Citation: Breast Cancer Research 2023 25:54
  13. CHEK2 c.1100delC was the first moderate-risk breast cancer (BC) susceptibility allele discovered. Despite several genomic, transcriptomic and functional studies, however, it is still unclear how exactly CHEK2 c.1...

    Authors: Marcel Smid, Marjanka K. Schmidt, Wendy J. C. Prager-van der Smissen, Kirsten Ruigrok-Ritstier, Maartje A. C. Schreurs, Sten Cornelissen, Aida Marsal Garcia, Annegien Broeks, A. Mieke Timmermans, Anita M. A. C. Trapman-Jansen, J. Margriet Collée, Muriel A. Adank, Maartje J. Hooning, John W. M. Martens and Antoinette Hollestelle
    Citation: Breast Cancer Research 2023 25:53
  14. In light of the growing appreciation for the role of collective cell motility in metastasis, a deeper understanding of the underlying signaling pathways will be critical to translating these observations to th...

    Authors: Kacey VanderVorst, Courtney A. Dreyer, Jason Hatakeyama, George R. R. Bell, Julie A. Learn, Anastasia L. Berg, Maria Hernandez, Hyun Lee, Sean R. Collins and Kermit L. Carraway III
    Citation: Breast Cancer Research 2023 25:52
  15. Triple-negative breast cancer (TNBC) is a subtype of breast cancer with limited treatment options and poor clinical prognosis. Inhibitors of transcriptional CDKs are currently under thorough investigation for ...

    Authors: Vera E. van der Noord, Wanda van der Stel, Gijs Louwerens, Danielle Verhoeven, Hendrik J. Kuiken, Cor Lieftink, Melanie Grandits, Gerhard F. Ecker, Roderick L. Beijersbergen, Peter Bouwman, Sylvia E. Le Dévédec and Bob van de Water
    Citation: Breast Cancer Research 2023 25:51
  16. Breast cancer survivors are living longer due to early detection and advances in treatment and are at increased risk for second primary cancers. Comprehensive evaluation of second cancer risk among patients tr...

    Authors: Cody Ramin, Lene H. S. Veiga, Jacqueline B. Vo, Rochelle E. Curtis, Clara Bodelon, Erin J. Aiello Bowles, Diana S. M. Buist, Sheila Weinmann, Heather Spencer Feigelson, Gretchen L. Gierach and Amy Berrington de Gonzalez
    Citation: Breast Cancer Research 2023 25:50
  17. Insomnia is a highly prevalent symptom occurred during and post-chemotherapy. Acupuncture may have beneficial effects in the management of chemotherapy-associated insomnia. This study was conducted to determin...

    Authors: Jialing Zhang, Zongshi Qin, Tsz Him So, Tien Yee Chang, Sichang Yang, Haiyong Chen, Wing Fai Yeung, Ka Fai Chung, Pui Yan Chan, Yong Huang, Shifen Xu, Chun Yuan Chiang, Lixing Lao and Zhang-Jin Zhang
    Citation: Breast Cancer Research 2023 25:49
  18. Recent genomics studies of breast cancer in Asian cohorts have found a higher prevalence of TP53 mutations in Asian breast cancer patients relative to Caucasian patients. However, the effect of TP53 mutations on ...

    Authors: Mohana Eswari Ragu, Joanna Mei Ch’wan Lim, Pei-Sze Ng, Cheng-Har Yip, Pathmanathan Rajadurai, Soo-Hwang Teo and Jia-Wern Pan
    Citation: Breast Cancer Research 2023 25:48
  19. Breast cancer (BC) is one of the most burdensome cancers worldwide. Despite advancements in diagnostic and treatment modalities, developing countries are still dealing with increasing burdens and existing disp...

    Authors: Armin Aryannejad, Sahar Saeedi Moghaddam, Baharnaz Mashinchi, Mohammadreza Tabary, Negar Rezaei, Sarvenaz Shahin, Nazila Rezaei, Mohsen Naghavi, Bagher Larijani and Farshad Farzadfar
    Citation: Breast Cancer Research 2023 25:47
  20. Carbonic anhydrases catalyze CO2/HCO3 buffer reactions with implications for effective H+ mobility, pH dynamics, and cellular acid–base sensing. Yet, the integrated consequences of carbonic anhydrases for cancer...

    Authors: Soojung Lee, Nicolai J. Toft, Trine V. Axelsen, Maria Sofia Espejo, Tina M. Pedersen, Marco Mele, Helene L. Pedersen, Eva Balling, Tonje Johansen, Mark Burton, Mads Thomassen, Pernille Vahl, Peer Christiansen and Ebbe Boedtkjer
    Citation: Breast Cancer Research 2023 25:46
  21. Modifiable risk factors (alcohol, smoking, obesity, hormone use, and physical activity) affect a woman’s breast cancer (BC) risk. Whether these factors affect BC risk in women with inherited risk (family histo...

    Authors: Sarah Y. Cohen, Carolyn R. Stoll, Akila Anandarajah, Michelle Doering and Graham A. Colditz
    Citation: Breast Cancer Research 2023 25:45
  22. Triple-negative breast cancer (TNBC) affects young women and is the most aggressive subtype of breast cancer (BC). TNBCs disproportionally affect women of African-American (AA) descent compared to other ethni...

    Authors: Chinnadurai Mani, Ganesh Acharya, Karunakar Saamarthy, Damieanus Ochola, Srinidhi Mereddy, Kevin Pruitt, Upender Manne and Komaraiah Palle
    Citation: Breast Cancer Research 2023 25:44
  23. Triple-negative breast cancer (TNBC) exhibits the poorest outcomes among breast cancer subtypes due to the high heterogeneity and a lasting scarcity of effectual treatments. Targeted therapies based on molecul...

    Authors: Heshu Liu, Rui Yan, Zeru Xiao, Xuying Huang, Jiannan Yao, Jian Liu, Guangyu An and Yang Ge
    Citation: Breast Cancer Research 2023 25:43
  24. Experimental studies suggest a role for osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in mammary tumor development and progression. These biomarkers have been minima...

    Authors: Charlotte Le Cornet, Audrey Y. Jung, Theron S. Johnson, Sabine Behrens, Nadia Obi, Heiko Becher, Jenny Chang-Claude and Renée T. Fortner
    Citation: Breast Cancer Research 2023 25:42
  25. Cell adhesion is indispensable for appropriate tissue architecture and function in multicellular organisms. Besides maintaining tissue integrity, cell adhesion molecules, including tight-junction proteins clau...

    Authors: Yuko Murakami-Nishimagi, Kotaro Sugimoto, Makoto Kobayashi, Kazunoshin Tachibana, Manabu Kojima, Maiko Okano, Yuko Hashimoto, Shigehira Saji, Tohru Ohtake and Hideki Chiba
    Citation: Breast Cancer Research 2023 25:41
  26. Hormone receptor (HR)-positive, HER2/neu-negative breast cancers have a sustained risk of recurrence up to 20 years from diagnosis. TEAM (Tamoxifen, Exemestane Adjuvant Multinational) is a large, multi-country...

    Authors: Xi Zhang, Aparna Gunda, Elma Meershoek-Klein Kranenbarg, Gerrit-Jan Liefers, Badada Ananthamurthy Savitha, Payal Shrivastava, Chandra Prakash Vijay Kumar Serkad, Taranjot Kaur, Mallikarjuna Siraganahalli Eshwaraiah, Rob A. E. M. Tollenaar, Cornelis J. H. van de Velde, Caroline M. J. Seynaeve, Manjiri Bakre and Peter J. K. Kuppen
    Citation: Breast Cancer Research 2023 25:40
  27. Ki67 assessed at diagnosis (Ki67baseline) is an important prognostic factor in primary oestrogen receptor-positive (ER +) breast cancer. Proportional change in Ki67 after 2 weeks (∆Ki672week) is associated with c...

    Authors: Judith M. Bliss, Holly Tovey, Abigail Evans, Chris Holcombe, Kieran Horgan, Elizabeth Mallon, Raghavan Vidya, Anthony Skene, Andrew Dodson, Margaret Hills, Simone Detre, Lila Zabaglo, Jane Banerji, Lucy Kilburn, James P. Morden, John F. R. Robertson…
    Citation: Breast Cancer Research 2023 25:39
  28. Radiotherapy is widely applied in breast cancer treatment, while radiotherapy resistance is inevitable. TGF-β1 has been considered to be an endogenous factor for the development of radiotherapy resistance. As ...

    Authors: Fayun Zhang, Zifeng Zheng, Luoyang Wang, Wenfeng Zeng, Wenjing Wei, Chunling Zhang, Ziran Zhao and Wei Liang
    Citation: Breast Cancer Research 2023 25:38
  29. Metastasis is a multistep process that leads to the formation of clinically detectable tumor foci at distant organs and frequently to patient demise. Only a subpopulation of breast cancer cells within the prim...

    Authors: Camille L. Duran, George S. Karagiannis, Xiaoming Chen, Ved P. Sharma, David Entenberg, John S. Condeelis and Maja H. Oktay
    Citation: Breast Cancer Research 2023 25:37
  30. When ipsilateral multifocal primary breast cancer (IMBC) is detected, standard routine is to evaluate the largest tumor with immunohistochemistry (IHC). As all foci are not routinely characterized, many patien...

    Authors: Slavica Janeva, Ellen Krabbe, Toshima Z. Parris, Salmir Nasic, Marie Sundquist, Per Karlsson, Riccardo A. Audisio, Roger Olofsson Bagge and Anikó Kovács
    Citation: Breast Cancer Research 2023 25:36
  31. High mammographic breast density (MBD) is an established risk factor for breast cancer (BC). Body fatness conveys an increased BC risk in postmenopause but is associated with less dense breasts. Here, we studi...

    Authors: Giovanna Masala, Benedetta Bendinelli, Saverio Caini, Giacomo Duroni, Ilaria Ermini, Elisa Pastore, Miriam Fontana, Luigi Facchini, Andrea Querci, Maria Antonietta Gilio, Vincenzo Mazzalupo, Melania Assedi, Daniela Ambrogetti and Domenico Palli
    Citation: Breast Cancer Research 2023 25:35
  32. HER2-low could be found in some patients with triple-negative breast cancer (TNBC). However, its potential impacts on clinical features and tumor biological characteristics in TNBC remain unclear.

    Authors: Xi′e Hu, Ping Yang, Songhao Chen, Gang Wei, Lijuan Yuan, Zhenyu Yang, Li Gong, Li He, Lin Yang, Shujia Peng, Yanming Dong, Xianli He and Guoqiang Bao
    Citation: Breast Cancer Research 2023 25:34
  33. We investigated the associations of alcohol with percentage of epithelium, stroma, fibroglandular tissue (epithelium + stroma), and fat in benign breast biopsy samples.

    Authors: Lusine Yaghjyan, Yujing J. Heng, Gabrielle M. Baker, Bernard A. Rosner and Rulla M. Tamimi
    Citation: Breast Cancer Research 2023 25:33
  34. Disseminated tumor cells (DTCs) in the bone marrow are observed in about 40% at primary diagnosis of breast cancer and predict poor survival. While anti-resorptive therapy with bisphosphonates was shown to era...

    Authors: Pauline Wimberger, Jens-Uwe Blohmer, Petra Krabisch, Theresa Link, Marianne Just, Bruno Valentin Sinn, Eike Simon, Christine Solbach, Tanja Fehm, Carsten Denkert, Cristin Kühn, Kerstin Rhiem, Hans Tesch, Sherko Kümmel, Andrea Petzold, Oliver Stötzer…
    Citation: Breast Cancer Research 2023 25:32
  35. Metastatic breast cancer is responsible for the death of the majority of breast cancer patients. In fact, metastatic BC is the 2nd leading cause of cancer-related deaths in women in the USA and worldwide. Trip...

    Authors: Wei Wang, Priyanka S. Rana, Vesna Markovic and Khalid Sossey-Alaoui
    Citation: Breast Cancer Research 2023 25:31
  36. Breast cancer (BC) treatments and related symptoms may affect return to work (RTW). The objective of this study was to investigate the impact of BC care pathways (timing and sequence of treatments) and related...

    Authors: Anne-Lise Rolland, Bertrand Porro, Sofiane Kab, Céline Ribet, Yves Roquelaure and Mélanie Bertin
    Citation: Breast Cancer Research 2023 25:30
  37. Metastatic breast cancer (MBC) is a challenging disease, and despite new therapies, prognosis is still poor for a majority of patients. There is a clinical need for improved prognostication where immuno-oncolo...

    Authors: Frida Björk Gunnarsdottir, Pär-Ola Bendahl, Alexandra Johansson, Rui Benfeitas, Lisa Rydén, Caroline Bergenfelz and Anna-Maria Larsson
    Citation: Breast Cancer Research 2023 25:29
  38. Authors: Toru Hanamura, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Mayako Terao, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Takayuki Iwamoto, Chikako Honda, Sasagu Kurozumi and Naoki Niikura
    Citation: Breast Cancer Research 2023 25:28

    The original article was published in Breast Cancer Research 2023 25:13

  39. Inflammatory alterations of the extracellular matrix shape the tumor microenvironment and promote all stages of carcinogenesis. This study aims to determine the impact of cellular fibronectin on inflammatory f...

    Authors: Gurcan Tunali, Hamdullah Yanik, Suleyman Can Ozturk, Secil Demirkol-Canli, Georgios Efthymiou, Kerim Bora Yilmaz, Ellen Van Obberghen-Schilling and Gunes Esendagli
    Citation: Breast Cancer Research 2023 25:27
  40. RET, a single-pass receptor tyrosine kinase encoded on human chromosome 10, is well known to the field of developmental biology for its role in the ontogenesis of the central and enteric nervous systems and th...

    Authors: Geoffrey Pecar, Simeng Liu, Jagmohan Hooda, Jennifer M. Atkinson, Steffi Oesterreich and Adrian V. Lee
    Citation: Breast Cancer Research 2023 25:26
  41. Triple-negative breast cancer (TNBC) is highly aggressive with an increased metastatic incidence compared to other breast cancer subtypes. However, due to the absence of clinically reliable biomarkers and targ...

    Authors: Sanjib Chaudhary, Muthamil Iniyan Appadurai, Shailendra Kumar Maurya, Palanisamy Nallasamy, Saravanakumar Marimuthu, Ashu Shah, Pranita Atri, Chirravuri Venkata Ramakanth, Subodh M. Lele, Parthasarathy Seshacharyulu, Moorthy P. Ponnusamy, Mohd W. Nasser, Apar Kishor Ganti, Surinder K. Batra and Imayavaramban Lakshmanan
    Citation: Breast Cancer Research 2023 25:25
  42. Higher circulating prolactin has been associated with increased breast cancer risk. Prolactin binding to the prolactin receptor (PRLR) can activate the transcription factor STAT5, thus, we examined the associa...

    Authors: Cassandra A. Hathaway, Megan S. Rice, Laura C. Collins, Dilys Chen, David A. Frank, Sarah Walker, Charles V. Clevenger, Rulla M. Tamimi, Shelley S. Tworoger and Susan E. Hankinson
    Citation: Breast Cancer Research 2023 25:24
  43. Stratifying breast cancer into specific molecular or histologic subtypes aids in therapeutic decision-making and predicting outcomes; however, these subtypes may not be as distinct as previously thought. Patie...

    Authors: Gadisti Aisha Mohamed, Sundis Mahmood, Nevena B. Ognjenovic, Min Kyung Lee, Owen M. Wilkins, Brock C. Christensen, Kristen E. Muller and Diwakar R. Pattabiraman
    Citation: Breast Cancer Research 2023 25:23
  44. Breast cancer is the major cause of death in females globally. Chemokine-like factor like MARVEL transmembrane domain containing 7 (CMTM7) is reported as a tumor suppressor and is involved in epidermal growth ...

    Authors: Zhao-Hui Chen, Yao Tian, Guang-Lei Zhou, Hao-Ran Yue, Xue-Jie Zhou, Hai-Yan Ma, Jie Ge, Xin Wang, Xu-Chen Cao and Yue Yu
    Citation: Breast Cancer Research 2023 25:22
  45. The intratumor heterogeneity (ITH) of cancer cells plays an important role in breast cancer resistance and recurrence. To develop better therapeutic strategies, it is necessary to understand the molecular mech...

    Authors: Sumito Saeki, Kohei Kumegawa, Yoko Takahashi, Liying  Yang, Tomo Osako, Mahmut Yasen, Kazutaka Otsuji, Kenichi Miyata, Kaoru Yamakawa, Jun Suzuka, Yuri Sakimoto, Yukinori Ozaki, Toshimi Takano, Takeshi Sano, Tetsuo Noda, Shinji Ohno…
    Citation: Breast Cancer Research 2023 25:21
  46. Mammography screening has been proven to detect breast cancer at an early stage and reduce mortality; however, it has low accuracy in young women or women with dense breasts. Blood-based diagnostic tools may o...

    Authors: Eun-Shin Lee, Yumi Kim, Hee-Chul Shin, Ki-Tae Hwang, Junwon Min, Min Kyoon Kim, SooKyung Ahn, So-Youn Jung, Hyukjai Shin, MinSung Chung, Tae-Kyung Yoo, Seungpil Jung, Sang Uk Woo, Ju-Yeon Kim, Dong-Young Noh and Hyeong-Gon Moon
    Citation: Breast Cancer Research 2023 25:20
  47. Chemotherapy is an important strategy for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+HER2−) breast cancer (BC), but this subtype has a low response rate to...

    Authors: Dengjie Ouyang, Tao Hong, Mengdie Fu, Yitong Li, Liyun Zeng, Qitong Chen, Hongye He, Ying Wen, Yan Cheng, Meirong Zhou, Qiongyan Zou and Wenjun Yi
    Citation: Breast Cancer Research 2023 25:19
  48. Second primary cancer incidence is rising among breast cancer survivors. We examined the risks of non-breast second primaries, in combination and at specific cancer sites, through a systematic review and meta-...

    Authors: Isaac Allen, Hend Hassan, Eleni Sofianopoulou, Diana Eccles, Clare Turnbull, Marc Tischkowitz, Paul Pharoah and Antonis C. Antoniou
    Citation: Breast Cancer Research 2023 25:18
  49. Authors: Mikhail V. Pavlov, Anna P. Bavrina, Vladimir I. Plekhanov, German Yu. Golubyatnikov, Anna G. Orlova, Pavel V. Subochev, Diana A. Davydova, Ilya V. Turchin and Anna V. Maslennikova
    Citation: Breast Cancer Research 2023 25:16

    The original article was published in Breast Cancer Research 2023 25:12

Annual Journal Metrics